Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34500263)
Watch
English
Combination therapy in peripheral vascular disease: the rationale of using both thrombolytic and antiplatelet drugs.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Combination therapy in peripheral vascular disease: the rationale of using both thrombolytic and antiplatelet drugs
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
main subject
thrombolysis
1 reference
based on heuristic
inferred from title
vascular disease
1 reference
based on heuristic
inferred from title
author
Richard D Shlansky-Goldberg
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
author name string
Richard Shlansky-Goldberg
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
retrieved
2 August 2017
publication date
1 January 2002
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
published in
Journal of the American College of Surgeons
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
volume
194
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
issue
1 Suppl
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
page(s)
S103-13
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
cites work
Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acceleration of thrombolysis with a high-dose transthrombus bolus technique.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multilevel Infusion Catheter for Use with Thrombolytic Agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urokinase thrombolysis using a multiple side hole multilumen infusion catheter
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Symptomatic native arterial occlusions: early experience with "over-the-wire" thrombolysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
THROMBASTHENIA. STUDIES ON THREE CASES
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's Thrombasthenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombosis and the role of the platelet
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recognition of the importance of embolization in atherosclerotic vascular disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IIb's are not IIb's
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacology of eptifibatide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelets and thrombolytic therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The adjuvant use of the monoclonal antibody c7E3 Fab in peripheral arterial thrombolysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet glycoprotein IIb/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1072-7515%2801%2901098-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1072-7515(01)01098-5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
PubMed publication ID
11800349
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11800349
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11800349%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit